3rd party naloxone distribution

[Amy Bligh]

Does anyone have articles or studies that show how 3^rd party distribution of naloxone is helpful in the overdose epidemic?   Something with numbers and percentages of lived saved by non users ?

Amy Bligh, LADC (she/her)

Counseling Team Lead

Behavioral Health Group, LLC

2215 S. 6^th Street  Brainerd, MN  56401

Direct: 651-317-9902

Main: 218-454-1010

Fax: 218-454-3151

amy....@bhgrecovery.com

 

Confidentiality: This email (including attachments) may contain confidential, proprietary, and privileged information. Any unauthorized disclosure or use is prohibited. If you received this email in error, please notify the sender and delete this email from your system.

 

**Confidentiality** This email (including attachments) may contain confidential, proprietary, and privileged information. Any unauthorized disclosure or use is prohibited. If you received this email in error, please notify the sender and delete this email from your system. **Confidentiality** This email (including attachments) may contain confidential, proprietary, and privileged information. Any unauthorized disclosure or use is prohibited. If you received this email in error, please notify the sender and delete this email from your system.

[Andre Robinson]

Here are some articles I found this morning!

 

Impact of a community-based naloxone distribution program on opioid overdose death rates

https://www.sciencedirect.com/science/article/pii/S0376871619302959?casa_token=TTHRIdKFV0gAAAAA:ZyGNammgsVRQi1dlKuXPtgCqGZIABdReKtZgXbwiIw6mLDV2WPSsMReVfaMUDjdtdWYldyn3cw

“The rate of OOD in counties with 1–100 cumulative naloxone kits distributed per 100,000 population was 0.90 times (95% CI: 0.78, 1.04) that of counties that had not received kits. By December 2016, an estimated 352 NC deaths were avoided by naloxone distribution”

 

Rapid widespread distribution of intranasal naloxone for overdose prevention

https://www.sciencedirect.com/science/article/pii/S0376871617300315

“There were 2056 naloxone sprays distributed from one of the 20 participating facilities, with 277 reports of successful reversals.”

 

Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0315026

“70,234 naloxone doses dispensed, with 5,521 overdose response events (OREs), utilizing 8,756 naloxone doses… Long-term consistency of <2 doses per ORE, high survival rate, and robust utilization all lend confidence in prioritizing naloxone distribution directly to people who use drugs and their social networks.”

 

A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs

https://journals.lww.com/journaladdictionmedicine/abstract/2014/05000/a_systematic_review_of_community_opioid_overdose.1.aspx

“The current evidence from nonrandomized studies suggests that bystanders (mostly opioid users) can and will use naloxone to reverse opioid overdoses when properly trained”

 

The impact of a pharmacist-led naloxone education and community distribution project on local use of naloxone

https://www.sciencedirect.com/science/article/abs/pii/S1544319119305357

“Naloxone was utilized by 3.5% of respondents over an average of 3 months.” (I think this was distribution to the community in general, not necessarily PWUD)

 

Effectiveness of naloxone distribution in community settings to reduce opioid overdose deaths among people who use drugs: a systematic review and meta-analysis

https://link.springer.com/article/10.1186/s12889-025-22210-8

“Among the 44 Group 1 studies published during 2003–2018, survival did not differ by time (year), location, naloxone dose, or route of administration, but studies of OEND programs serving people who use drugs reported 98.3% (95% CI: 97.5–98.8) survival; those serving family of people who use drugs or other community members reported 95.0% (95% CI: 91.4–97.1) survival; and those for police reported 92.4% (95% CI: 88.9–94.8) survival (p < 0.01).”

 

Hope this helps!

 

 

André Robinson, MPH

He/Him

Community Health Worker, Sr – Substance Use Disorder

Office Phone: 612-543-3546

Work Cell: 612-578-0832

Northpoint Health and Wellness

2220 Plymouth Ave N, Minneapolis, MN 55411

 

From: 'Amy Bligh' via SSPMeeting <sspme...@googlegroups.com>
Sent: Saturday, March 14, 2026 10:07 AM
To: ssp group <sspme...@googlegroups.com>
Subject: [External] [SSP Meeting] 3rd party naloxone distribution

 

CAUTION: This email was sent from outside of Hennepin County. Unless you recognize the sender and know the content, do not click links or open attachments.

--
You received this message because you are subscribed to the Google Groups "SSPMeeting" group.
To unsubscribe from this group and stop receiving emails from it, send an email to sspmeeting+...@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/sspmeeting/MW4PR19MB67708B77AA08DB60051BC2BEE842A%40MW4PR19MB6770.namprd19.prod.outlook.com.

Disclaimer: If you are not the intended recipient of this message, please immediately notify the sender of the transmission error and then promptly permanently delete this message from your computer system.